Oral dosage form

Latest Johnson & Johnson Consumer Inc. Patents:

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a perspective view of an oral dosage form showing my new design, wherein the shading at the ends is understood to represent the color red;

FIG. 2 is a side elevational view thereof, the opposite side being a mirror image of the side elevational view of FIG. 2;

FIG. 3 is a plan view thereof, the opposite side being a mirror image of the plan view of FIG. 3;

FIG. 4 is an end view thereof, the opposite end being a mirror image of the end view of FIG. 4;

FIG. 5 is a perspective view of an oral dosage form showing my new design, wherein the stippled shading at the top and bottom ends is understood to represent a color contrasting with the central region;

FIG. 6 is a side elevational view of the oral dosage form of FIG. 5, the opposite side being a mirror image of the side elevational view of FIG. 6;

FIG. 7 is a plan view of the oral dosage form of FIG. 5, the opposite side being a mirror image of the plan view of FIG. 7; and,

FIG. 8 is an end view of the oral dosage form of FIG. 5, the opposite end being a mirror image of the end view of FIG. 8.

Claims

We claim the ornamental design for an oral dosage form, as shown and described.

Referenced Cited
U.S. Patent Documents
D31133 July 1899 Lantz
2584166 February 1952 Stevenson et al.
3048526 August 1962 Boswell
3281620 October 1966 Keith
3426453 February 1969 Dingwell et al.
D237199 October 1975 Sauter
4034035 July 5, 1977 Schwartz et al.
D258091 January 27, 1981 Reed et al.
D286086 October 7, 1986 Tovey
4713248 December 15, 1987 Kjornaes et al.
4820524 April 11, 1989 Berta
D301762 June 20, 1989 Oshlack
4851230 July 25, 1989 Tencza et al.
4966771 October 30, 1990 Berta
D315223 March 5, 1991 Estwin
5089270 February 18, 1992 Hampton et al.
5146730 September 15, 1992 Sadek et al.
5658589 August 19, 1997 Parekh et al.
5683718 November 4, 1997 Errigo
5770225 June 23, 1998 Parekh et al.
D396455 July 28, 1998 Bier
5824338 October 20, 1998 Jacobs et al.
D403673 January 5, 1999 Arora et al.
D408910 April 27, 1999 Lundbom et al.
5916592 June 29, 1999 Parekh et al.
6113945 September 5, 2000 Jacobs et al.
6120801 September 19, 2000 Parekh et al.
6214380 April 10, 2001 Parekh et al.
6326026 December 4, 2001 Parekh et al.
6482516 November 19, 2002 Sadek et al.
D471227 March 4, 2003 Gray
D500766 January 11, 2005 Hanisch et al.
D500849 January 11, 2005 Rinker
D506544 June 21, 2005 Rinker et al.
6946156 September 20, 2005 Bunick
D525356 July 18, 2006 Rinker et al.
7087242 August 8, 2006 Parekh et al.
D534646 January 2, 2007 Chang
D535389 January 16, 2007 Stawski et al.
7169450 January 30, 2007 Bunick
D544495 June 12, 2007 Evans et al.
D549724 August 28, 2007 Niijima
D549725 August 28, 2007 Niijima
D569874 May 27, 2008 Wasko et al.
7429619 September 30, 2008 Kamath
D580547 November 11, 2008 Lolis et al.
D597098 July 28, 2009 Su et al.
D631537 January 25, 2011 Sadler
D667430 September 18, 2012 Ouilhet et al.
20040146559 July 29, 2004 Sowden et al.
20070026064 February 1, 2007 Yoder et al.
20070031488 February 8, 2007 Solomon et al.
20070048365 March 1, 2007 Rao
20070048369 March 1, 2007 Foreman et al.
20070098931 May 3, 2007 Bunick et al.
20070134321 June 14, 2007 Solomon et al.
20070190133 August 16, 2007 Bunick et al.
20070224258 September 27, 2007 Bunick et al.
20070231389 October 4, 2007 Bunick et al.
20070281022 December 6, 2007 Bunick et al.
20080069880 March 20, 2008 Bunick
20080075766 March 27, 2008 Li et al.
20080187581 August 7, 2008 Gore et al.
20080317677 December 25, 2008 Szymczak
20080317678 December 25, 2008 Szymczak
20090087483 April 2, 2009 Sison
20090148520 June 11, 2009 Arima et al.
20090155361 June 18, 2009 Narasaki et al.
20090175939 July 9, 2009 Bosse et al.
20090181082 July 16, 2009 Zuniga et al.
Other references
  • Pentasa—ca pre Oct. 2001.
  • Rescon—ca pre Sep. 2009.
  • Pseudoephedrine—Guaifenesin CR—ca pre Sep. 2009.
  • Prenatal Combopak—ca pre Sep. 2009.
  • DOK—ca pre Sep. 2009.
  • Hydergine LC—ca pre Sep. 2009.
  • Isradipine—ca pre Sep. 2009.
  • Lamotrigine (chewable, dispersible)—ca pre Sep. 2009.
  • Cyclosporine—ca pre Sep. 2009.
  • Benazepril—hydrochlorothiazide—ca pre Sep. 2009.
  • Verapamil hydrochloride—ca pre Sep. 2009.
  • Item #613 p. 110 Symbols, Signs & Signets by Ernst Lehner 1950.
Patent History
Patent number: D773641
Type: Grant
Filed: Jul 13, 2015
Date of Patent: Dec 6, 2016
Assignee: Johnson & Johnson Consumer Inc. (Skillman, NJ)
Inventors: Neil A. Sadler (Weehawken, NJ), Jeffrey S. Silva (Jersey City, NJ)
Primary Examiner: Charles Hanson
Application Number: 29/532,943
Classifications
Current U.S. Class: Tablet Or Caplet (1) (D24/101)